[{"id":"aa19e127-4a6d-4543-94a8-fa9ef6096cb6","acronym":"","url":"https://clinicaltrials.gov/study/NCT05881525","created_at":"2023-05-31T15:05:39.768Z","updated_at":"2024-07-02T16:35:09.880Z","phase":"Phase 1","brief_title":"NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors","source_id_and_acronym":"NCT05881525","lead_sponsor":"TCRCure Biopharma Ltd.","biomarkers":" CTAG1B","pipe":" | ","alterations":" CTAG1B expression","tags":["CTAG1B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CTAG1B expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e albumin-bound paclitaxel • cyclophosphamide • fludarabine IV • N201"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 06/01/2023","start_date":" 06/01/2023","primary_txt":" Primary completion: 10/01/2024","primary_completion_date":" 10/01/2024","study_txt":" Completion: 03/01/2025","study_completion_date":" 03/01/2025","last_update_posted":"2024-04-12"}]